Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03010035 PGA2 cPLA2i 1.0 BCD110605C28 0.139 pmol/ml medium
LMFA03010035 PGA2 cPLA2i 1.0 BCD110605C30 0.19 pmol/ml medium
LMFA03010035 PGA2 cPLA2i 1.0 BCD110605C29 0.189 pmol/ml medium
LMFA03010035 PGA2 cPLA2i 20.0 BCD110605C64 0.193 pmol/ml medium
LMFA03010035 PGA2 cPLA2i 20.0 BCD110605C66 0.218 pmol/ml medium
LMFA03010035 PGA2 cPLA2i 20.0 BCD110605C65 0.204 pmol/ml medium
LMFA03010035 PGA2 PLDi 1.0 BCD110605C16 0.17 pmol/ml medium
LMFA03010035 PGA2 PLDi 1.0 BCD110605C17 0.156 pmol/ml medium
LMFA03010035 PGA2 PLDi 1.0 BCD110605C18 0.149 pmol/ml medium
LMFA03010035 PGA2 PLDi 20.0 BCD110605C54 0.112 pmol/ml medium
LMFA03010035 PGA2 PLDi 20.0 BCD110605C52 0.154 pmol/ml medium
LMFA03010035 PGA2 PLDi 20.0 BCD110605C53 0.127 pmol/ml medium
LMFA03010035 PGA2 KDO+cPLA2i 1.0 BCD110605C32 0.192 pmol/ml medium
LMFA03010035 PGA2 KDO+cPLA2i 1.0 BCD110605C31 0.173 pmol/ml medium
LMFA03010035 PGA2 KDO+cPLA2i 1.0 BCD110605C33 0.208 pmol/ml medium
LMFA03010035 PGA2 KDO+cPLA2i 20.0 BCD110605C68 0.186 pmol/ml medium
LMFA03010035 PGA2 KDO+cPLA2i 20.0 BCD110605C69 0.223 pmol/ml medium
LMFA03010035 PGA2 KDO+cPLA2i 20.0 BCD110605C67 0.24 pmol/ml medium
LMFA03010035 PGA2 KDO+PLDi 1.0 BCD110605C19 0.146 pmol/ml medium
LMFA03010035 PGA2 KDO+PLDi 1.0 BCD110605C20 0.188 pmol/ml medium
LMFA03010035 PGA2 KDO+PLDi 1.0 BCD110605C21 0.173 pmol/ml medium
LMFA03010035 PGA2 KDO+PLDi 20.0 BCD110605C56 0.15 pmol/ml medium
LMFA03010035 PGA2 KDO+PLDi 20.0 BCD110605C57 0.147 pmol/ml medium
LMFA03010035 PGA2 KDO+PLDi 20.0 BCD110605C55 0.146 pmol/ml medium
LMFA03010035 PGA2 KDO+ATP+cPLA2i 1.0 BCD110605C37 0.272 pmol/ml medium
LMFA03010035 PGA2 KDO+ATP+cPLA2i 1.0 BCD110605C38 0.19 pmol/ml medium
LMFA03010035 PGA2 KDO+ATP+cPLA2i 1.0 BCD110605C39 0.273 pmol/ml medium
LMFA03010035 PGA2 KDO+ATP+cPLA2i 20.0 BCD110605C74 0.27 pmol/ml medium
LMFA03010035 PGA2 KDO+ATP+cPLA2i 20.0 BCD110605C75 0.288 pmol/ml medium
LMFA03010035 PGA2 KDO+ATP+cPLA2i 20.0 BCD110605C73 0.233 pmol/ml medium
LMFA03010035 PGA2 KDO+ATP+PLDi 1.0 BCD110605C25 0.229 pmol/ml medium
LMFA03010035 PGA2 KDO+ATP+PLDi 1.0 BCD110605C27 0.231 pmol/ml medium
LMFA03010035 PGA2 KDO+ATP+PLDi 1.0 BCD110605C26 0.201 pmol/ml medium
LMFA03010035 PGA2 KDO+ATP+PLDi 20.0 BCD110605C61 0.215 pmol/ml medium
LMFA03010035 PGA2 KDO+ATP+PLDi 20.0 BCD110605C62 0.231 pmol/ml medium
LMFA03010035 PGA2 KDO+ATP+PLDi 20.0 BCD110605C63 0.129 pmol/ml medium
LMFA03010035 PGA2 KDO + ATP 1.0 BCD110605C15 0.191 pmol/ml medium
LMFA03010035 PGA2 KDO + ATP 1.0 BCD110605C14 0.164 pmol/ml medium
LMFA03010035 PGA2 KDO + ATP 1.0 BCD110605C13 0.185 pmol/ml medium
LMFA03010035 PGA2 KDO + ATP 20.0 BCD110605C49 0.195 pmol/ml medium
LMFA03010035 PGA2 KDO + ATP 20.0 BCD110605C50 0.223 pmol/ml medium
LMFA03010035 PGA2 KDO + ATP 20.0 BCD110605C51 0.211 pmol/ml medium
LMFA03010035 PGA2 KDO 1.0 BCD110605C08 0.132 pmol/ml medium
LMFA03010035 PGA2 KDO 1.0 BCD110605C07 0.118 pmol/ml medium
LMFA03010035 PGA2 KDO 1.0 BCD110605C09 0.153 pmol/ml medium
LMFA03010035 PGA2 KDO 20.0 BCD110605C45 0.129 pmol/ml medium
LMFA03010035 PGA2 KDO 20.0 BCD110605C44 0.152 pmol/ml medium
LMFA03010035 PGA2 KDO 20.0 BCD110605C43 0.118 pmol/ml medium
LMFA03010035 PGA2 C 0.0 BCD110605C03 0.12 pmol/ml medium
LMFA03010035 PGA2 C 0.0 BCD110605C01 0.254 pmol/ml medium